Your browser doesn't support javascript.
loading
Implications of IDH mutations on immunotherapeutic strategies for malignant glioma.
Richardson, Leland G; Miller, Julie J; Kitagawa, Yosuke; Wakimoto, Hiroaki; Choi, Bryan D; Curry, William T.
Afiliação
  • Richardson LG; 1Translational Brain Tumor Immunology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Miller JJ; 2Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and.
  • Kitagawa Y; 3Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wakimoto H; 2Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and.
  • Choi BD; 2Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and.
  • Curry WT; 1Translational Brain Tumor Immunology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Neurosurg Focus ; 52(2): E6, 2022 02.
Article em En | MEDLINE | ID: mdl-35104795
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article